The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
In Vitro Diagnostic Devices-Global Market Insights and Sales Trends 2024
Synopsis
The global In Vitro Diagnostic Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Diagnostic Devices in various end use industries. The expanding demands from the Hospitals, Laboratory and Other,, are propelling In Vitro Diagnostic Devices market. Immuno Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemistry Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Diagnostic Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Diagnostic Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Diagnostic Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Diagnostic Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Diagnostic Devices covered in this report include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics and Becton Dickinson, etc.
The global In Vitro Diagnostic Devices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
Biomerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
Johnson and Johnson
Qiagen
Myriad Genetics
Wondfo
KHB
DAAN Gene
Leadman Biochemistry
Mindray
BioSino
LG Chem
Global In Vitro Diagnostic Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Diagnostic Devices market, Segment by Type:
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Other
Global In Vitro Diagnostic Devices market, by Application
Hospitals
Laboratory
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Diagnostic Devices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global In Vitro Diagnostic Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of In Vitro Diagnostic Devices in various end use industries. The expanding demands from the Hospitals, Laboratory and Other,, are propelling In Vitro Diagnostic Devices market. Immuno Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemistry Diagnostics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for In Vitro Diagnostic Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global In Vitro Diagnostic Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global In Vitro Diagnostic Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, In Vitro Diagnostic Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of In Vitro Diagnostic Devices covered in this report include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, Biomerieux, Ortho Clinical Diagnostics and Becton Dickinson, etc.
The global In Vitro Diagnostic Devices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
Biomerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
Johnson and Johnson
Qiagen
Myriad Genetics
Wondfo
KHB
DAAN Gene
Leadman Biochemistry
Mindray
BioSino
LG Chem
Global In Vitro Diagnostic Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global In Vitro Diagnostic Devices market, Segment by Type:
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Other
Global In Vitro Diagnostic Devices market, by Application
Hospitals
Laboratory
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of In Vitro Diagnostic Devices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of In Vitro Diagnostic Devices
1.1 In Vitro Diagnostic Devices Market Overview
1.1.1 In Vitro Diagnostic Devices Product Scope
1.1.2 In Vitro Diagnostic Devices Market Status and Outlook
1.2 Global In Vitro Diagnostic Devices Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global In Vitro Diagnostic Devices Market Size by Region (2018-2029)
1.4 Global In Vitro Diagnostic Devices Historic Market Size by Region (2018-2023)
1.5 Global In Vitro Diagnostic Devices Market Size Forecast by Region (2024-2029)
1.6 Key Regions, In Vitro Diagnostic Devices Market Size (2018-2029)
1.6.1 North America In Vitro Diagnostic Devices Market Size (2018-2029)
1.6.2 Europe In Vitro Diagnostic Devices Market Size (2018-2029)
1.6.3 Asia-Pacific In Vitro Diagnostic Devices Market Size (2018-2029)
1.6.4 Latin America In Vitro Diagnostic Devices Market Size (2018-2029)
1.6.5 Middle East & Africa In Vitro Diagnostic Devices Market Size (2018-2029)
2 In Vitro Diagnostic Devices Market by Type
2.1 Introduction
2.1.1 Immuno Diagnostics
2.1.2 Chemistry Diagnostics
2.1.3 Molecular Diagnostics
2.1.4 POCT
2.1.5 Other
2.2 Global In Vitro Diagnostic Devices Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global In Vitro Diagnostic Devices Historic Market Size by Type (2018-2023)
2.2.2 Global In Vitro Diagnostic Devices Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America In Vitro Diagnostic Devices Revenue Breakdown by Type (2018-2029)
2.3.2 Europe In Vitro Diagnostic Devices Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific In Vitro Diagnostic Devices Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America In Vitro Diagnostic Devices Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa In Vitro Diagnostic Devices Revenue Breakdown by Type (2018-2029)
3 In Vitro Diagnostic Devices Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Laboratory
3.1.3 Other
3.2 Global In Vitro Diagnostic Devices Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global In Vitro Diagnostic Devices Historic Market Size by Application (2018-2023)
3.2.2 Global In Vitro Diagnostic Devices Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America In Vitro Diagnostic Devices Revenue Breakdown by Application (2018-2029)
3.3.2 Europe In Vitro Diagnostic Devices Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific In Vitro Diagnostic Devices Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America In Vitro Diagnostic Devices Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa In Vitro Diagnostic Devices Revenue Breakdown by Application (2018-2029)
4 In Vitro Diagnostic Devices Competition Analysis by Players
4.1 Global In Vitro Diagnostic Devices Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in In Vitro Diagnostic Devices as of 2022)
4.3 Date of Key Players Enter into In Vitro Diagnostic Devices Market
4.4 Global Top Players In Vitro Diagnostic Devices Headquarters and Area Served
4.5 Key Players In Vitro Diagnostic Devices Product Solution and Service
4.6 Competitive Status
4.6.1 In Vitro Diagnostic Devices Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche In Vitro Diagnostic Devices Products, Services and Solutions
5.1.4 Roche In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott In Vitro Diagnostic Devices Products, Services and Solutions
5.2.4 Abbott In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Danaher
5.3.1 Danaher Profile
5.3.2 Danaher Main Business
5.3.3 Danaher In Vitro Diagnostic Devices Products, Services and Solutions
5.3.4 Danaher In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Healthineers Recent Developments
5.4 Siemens Healthineers
5.4.1 Siemens Healthineers Profile
5.4.2 Siemens Healthineers Main Business
5.4.3 Siemens Healthineers In Vitro Diagnostic Devices Products, Services and Solutions
5.4.4 Siemens Healthineers In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Healthineers Recent Developments
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Profile
5.5.2 Thermo Fisher Scientific Main Business
5.5.3 Thermo Fisher Scientific In Vitro Diagnostic Devices Products, Services and Solutions
5.5.4 Thermo Fisher Scientific In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.5.5 Thermo Fisher Scientific Recent Developments
5.6 Sysmex
5.6.1 Sysmex Profile
5.6.2 Sysmex Main Business
5.6.3 Sysmex In Vitro Diagnostic Devices Products, Services and Solutions
5.6.4 Sysmex In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.6.5 Sysmex Recent Developments
5.7 Biomerieux
5.7.1 Biomerieux Profile
5.7.2 Biomerieux Main Business
5.7.3 Biomerieux In Vitro Diagnostic Devices Products, Services and Solutions
5.7.4 Biomerieux In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.7.5 Biomerieux Recent Developments
5.8 Ortho Clinical Diagnostics
5.8.1 Ortho Clinical Diagnostics Profile
5.8.2 Ortho Clinical Diagnostics Main Business
5.8.3 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Products, Services and Solutions
5.8.4 Ortho Clinical Diagnostics In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.8.5 Ortho Clinical Diagnostics Recent Developments
5.9 Becton Dickinson
5.9.1 Becton Dickinson Profile
5.9.2 Becton Dickinson Main Business
5.9.3 Becton Dickinson In Vitro Diagnostic Devices Products, Services and Solutions
5.9.4 Becton Dickinson In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.9.5 Becton Dickinson Recent Developments
5.10 Bio-Rad Laboratories
5.10.1 Bio-Rad Laboratories Profile
5.10.2 Bio-Rad Laboratories Main Business
5.10.3 Bio-Rad Laboratories In Vitro Diagnostic Devices Products, Services and Solutions
5.10.4 Bio-Rad Laboratories In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.10.5 Bio-Rad Laboratories Recent Developments
5.11 Hologic
5.11.1 Hologic Profile
5.11.2 Hologic Main Business
5.11.3 Hologic In Vitro Diagnostic Devices Products, Services and Solutions
5.11.4 Hologic In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.11.5 Hologic Recent Developments
5.12 Johnson and Johnson
5.12.1 Johnson and Johnson Profile
5.12.2 Johnson and Johnson Main Business
5.12.3 Johnson and Johnson In Vitro Diagnostic Devices Products, Services and Solutions
5.12.4 Johnson and Johnson In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.12.5 Johnson and Johnson Recent Developments
5.13 Qiagen
5.13.1 Qiagen Profile
5.13.2 Qiagen Main Business
5.13.3 Qiagen In Vitro Diagnostic Devices Products, Services and Solutions
5.13.4 Qiagen In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.13.5 Qiagen Recent Developments
5.14 Myriad Genetics
5.14.1 Myriad Genetics Profile
5.14.2 Myriad Genetics Main Business
5.14.3 Myriad Genetics In Vitro Diagnostic Devices Products, Services and Solutions
5.14.4 Myriad Genetics In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.14.5 Myriad Genetics Recent Developments
5.15 Wondfo
5.15.1 Wondfo Profile
5.15.2 Wondfo Main Business
5.15.3 Wondfo In Vitro Diagnostic Devices Products, Services and Solutions
5.15.4 Wondfo In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.15.5 Wondfo Recent Developments
5.16 KHB
5.16.1 KHB Profile
5.16.2 KHB Main Business
5.16.3 KHB In Vitro Diagnostic Devices Products, Services and Solutions
5.16.4 KHB In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.16.5 KHB Recent Developments
5.17 DAAN Gene
5.17.1 DAAN Gene Profile
5.17.2 DAAN Gene Main Business
5.17.3 DAAN Gene In Vitro Diagnostic Devices Products, Services and Solutions
5.17.4 DAAN Gene In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.17.5 DAAN Gene Recent Developments
5.18 Leadman Biochemistry
5.18.1 Leadman Biochemistry Profile
5.18.2 Leadman Biochemistry Main Business
5.18.3 Leadman Biochemistry In Vitro Diagnostic Devices Products, Services and Solutions
5.18.4 Leadman Biochemistry In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.18.5 Leadman Biochemistry Recent Developments
5.19 Mindray
5.19.1 Mindray Profile
5.19.2 Mindray Main Business
5.19.3 Mindray In Vitro Diagnostic Devices Products, Services and Solutions
5.19.4 Mindray In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.19.5 Mindray Recent Developments
5.20 BioSino
5.20.1 BioSino Profile
5.20.2 BioSino Main Business
5.20.3 BioSino In Vitro Diagnostic Devices Products, Services and Solutions
5.20.4 BioSino In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.20.5 BioSino Recent Developments
5.21 LG Chem
5.21.1 LG Chem Profile
5.21.2 LG Chem Main Business
5.21.3 LG Chem In Vitro Diagnostic Devices Products, Services and Solutions
5.21.4 LG Chem In Vitro Diagnostic Devices Revenue (US$ Million) & (2018-2023)
5.21.5 LG Chem Recent Developments
6 North America
6.1 North America In Vitro Diagnostic Devices Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe In Vitro Diagnostic Devices Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostic Devices Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America In Vitro Diagnostic Devices Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostic Devices Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 In Vitro Diagnostic Devices Market Dynamics
11.1 In Vitro Diagnostic Devices Industry Trends
11.2 In Vitro Diagnostic Devices Market Drivers
11.3 In Vitro Diagnostic Devices Market Challenges
11.4 In Vitro Diagnostic Devices Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
